用深度强化学习优化手术中低血压治疗,降低术后肾损伤风险。
Learning optimal treatment strategies for intraoperative hypotension using deep reinforcement learning
- 基于15分钟生理数据,用深度Q网络推荐液体和升压药剂量
- 模型建议用药与医生实际用药有69%一致,且降低肾损伤发生率
- 适合临床决策支持系统开发,尤其关注围术期管理的医生
传统手术决策依赖医生经验,存在较大变异性。针对术中低血压这一常见且易导致术后急性肾损伤(AKI)的并发症,我们构建了一个基于深度强化学习(RL)的模型,用于推荐术中静脉液体和血管活性药物的最佳剂量。回顾性分析了2014年6月至2020年9月期间某四级医疗中心42,547名成年患者共50,021例大型手术数据,其中34,186例用于训练,15,835例用于测试。模型使用16个变量,包括每15分钟一次的术中生理时间序列、液体及升压药累计剂量。结果表明,模型对升压药剂量的决策与医生一致率达69%,在10%情况下建议更高剂量,21%建议更低;液体推荐与实际剂量偏差小于0.05 ml/kg/15 min的比例为41%,27%建议更高,32%建议更低。相比医生实际用药、随机策略及零药物策略,该模型的预估策略价值更高,且接受模型推荐方案的患者中AKI发生率最低。研究提示,应用该模型有望减少术后肾损伤并改善其他由术中低血压驱动的不良结局。
原文摘要 · Abstract (English)
Traditional methods of surgical decision making heavily rely on human experience and prompt actions, which are variable. A data-driven system generating treatment recommendations based on patient states can be a substantial asset in perioperative decision-making, as in cases of intraoperative hypotension, for which suboptimal management is associated with acute kidney injury (AKI), a common and morbid postoperative complication. We developed a Reinforcement Learning (RL) model to recommend optimum dose of intravenous (IV) fluid and vasopressors during surgery to avoid intraoperative hypotension and postoperative AKI. We retrospectively analyzed 50,021 surgeries from 42,547 adult patients who underwent major surgery at a quaternary care hospital between June 2014 and September 2020. Of these, 34,186 surgeries were used for model training and 15,835 surgeries were reserved for testing. We developed a Deep Q-Networks based RL model using 16 variables including intraoperative physiologic time series, total dose of IV fluid and vasopressors extracted for every 15-minute epoch. The model replicated 69% of physician's decisions for the dosage of vasopressors and proposed higher or lower dosage of vasopressors than received in 10% and 21% of the treatments, respectively. In terms of IV fluids, the model's recommendations were within 0.05 ml/kg/15 min of the actual dose in 41% of the cases, with higher or lower doses recommended for 27% and 32% of the treatments, respectively. The model resulted in a higher estimated policy value compared to the physicians' actual treatments, as well as random and zero-drug policies. AKI prevalence was the lowest in patients receiving medication dosages that aligned with model's decisions. Our findings suggest that implementation of the model's policy has the potential to reduce postoperative AKI and improve other outcomes driven by intraoperative hypotension.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。